Analyst Ratings for Cancer Genetics, Inc. (CGIX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/9/2018 | Dawson James | N/A | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.20 (4.61) |
284.17% | Details |
| 4/3/2018 | Maxim Group | N/A | Downgrade | Hold (Buy) |
N/A (N/A) |
1.65 (4.61) |
179.39% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


